quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 27, 2026

CPP Investments and Equinix to Acquire atNorth for US$4 Billion

View original at finance.yahoo.com
CPP Investments and Equinix to Acquire atNorth for US$4 Billion Leading Data Center Provider in the Nordics Has Operations in Five Countries, Providing Equinix with Access to Capacity to Meet Enterprise, AI and Hyperscale Demand in Key Markets TORONTO and AMSTERDAM, Feb…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The transaction demonstrates CPP Investments' conviction and commitment to the data center sector where demand continues to accelerate

    80% confidence
  • The acquisition illustrates the strategic importance of the region as Europe's rising AI powerhouse

    80% confidence
  • The opportunity allows CPP Investments to deploy capital at scale into a high-quality platform to deliver attractive risk-adjusted returns

    80% confidence
  • The scalable sites of atNorth are very complementary to Equinix's connectivity services and global footprint

    80% confidence
  • The acquisition is expected to enhance Equinix's ability to help customers unlock the full potential of the Nordics' expanding digital landscape

    80% confidence
  • This acquisition is a powerful validation of atNorth's journey and its market position as the leading Nordics data center platform

    80% confidence
  • The transaction is expected to be immediately accretive upon close to Equinix's adjusted funds from operations (AFFO) per share

    80% confidence
  • The Nordics are an attractive market for data center growth

    80% confidence
  • atNorth will continue to operate independently under the atNorth brand, preserving dedication to communities and culture

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com